Skip to main content

Table 1 Distribution of the investigated pre-treatment characteristics

From: A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression

  N patients’
(%)
Age
 ≤ 65 years 332 (48)
 ≥ 66 years 354 (52)
Interval between initial tumor diagnosis and RT of MSCC
 ≤ 15 months 395 (58)
 > 15 months 291 (42)
Visceral metastases at the time of RT
 No 354 (52)
 Yes 332 (48)
Other bone metastases at the time of RT
 No 237 (35)
 Yes 449 (65)
Type of primary tumor
 Breast cancer 134 (20)
 Prostate cancer 140 (20)
 Myeloma/lymphoma 56 (8)
 Lung cancer 157 (23)
 Unknown primary 69 (10)
 Renal cell carcinoma 41 (6)
 Colorectal cancer 24 (3)
 Other tumors 65 (9)
Gender
 Female 265 (39)
 Male 421 (61)
Time developing motor deficits prior to RT
 1–7 days 228 (33)
 8–14 days 177 (26)
 > 14 days 281 (41)
Gait function prior to RT
 Not ambulatory 281 (41)
 Ambulatory 405 (59)
Number of vertebrae affected by MSCC
 1–2 279 (41)
 3–4 260 (38)
 ≥ 5 147 (21)
ECOG performance score
 1–2 317 (46)
 3 320 (47)
 4 49 (7)